尋找研究成果

搜尋結果

• A pilot study of citizens' opinions on the incident command system in Taiwan

  Lam, C., Lin, M-R., Tsai, S-H. & Chiu, W-T., 4月 2010, 於: Disasters. 34, 2, p. 447-469 23 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  6 引文 斯高帕斯（Scopus）

• A Pilot Study of Cisplatin, 5-Fluorouracil and High Dose Leucovorin in Chinese Patients with Head and Neck Cancer

  貢獻的翻譯標題: Cisplatin, 5Fluorouracil，高劑量Leucovorinl在中國人頭頸部癌病之前導性研究林增熙, 陳榮楷, 季匡華, 顏上惠(Sang H Y, 羅世薰(Su S L, 吳銘芳, 黃偉修(Wei S H, 彭汪嘉康(Jacqueline W-P, 劉敏(M L & 陳光耀(Kuang Y C, 1994, 於: 放射治療與腫瘤學. 1, 3, p. 263-268 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• A pilot study of ceramic powder far-infrared ray irradiation (cFIR) on physiology: Observation of cell cultures and amphibian skeletal muscle

  Leung, T. K., Lee, C. M., Tsai, S. Y., Chen, Y. C. & Chao, J. S., 2011, 於: Chinese Journal of Physiology. 54, 4

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  25 引文 斯高帕斯（Scopus）

• A pilot study of a new thrombolytic agent for acute ischemic stroke in Taiwan within a five-hour window

  Hu, H. H., Teng, M. M. H., Hsu, L. C., Wong, W. J., Wang, L. M., Luk, Y. O., Chern, C. M., Soong, B. W. & Sheng, W. Y., 3月 1 2006, 於: Stroke. 37, 3, p. 918-919 2 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  14 引文 斯高帕斯（Scopus）

• A pilot study for circadian gene disturbance in dementia patients

  Liu, H. C., Hu, C. J., Tang, Y. C. & Chang, J. G., 4月 25 2008, 於: Neuroscience Letters. 435, 3, p. 229-233 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  29 引文 斯高帕斯（Scopus）

• A pilot study comparing ergonomics in laparoscopy and robotics: beyond anecdotes, and subjective claims

  Kuo, L-J., Ngu, J. C-Y., Lin, Y-K., Chen, C-C. & Tang, Y-H., 2月 2020, 於: Journal of Surgical Case Reports. 2020, 2, p. rjaa005

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• A Pilot Safety Assessment for Recombinant Epinephelus lanceolatus Piscidin Yeast Powder as a Drug Food Additive after Subacute and Subchronic Administration to SD Rats

  Su, B. C., Li, C. C., Liu, C. W. & Chen, J. Y., 11月 24 2020, 於: Marine Drugs. 18, 12

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

• A pilot randomized controlled trial using Baduanjin qigong to reverse frailty status among post-treatment older cancer survivors

  Cheung, D. S. T., Chau, P. H., Lam, T. C., Ng, A. Y. M., Kwok, T. W. H., Takemura, N., Woo, J., Yu, D. S. F. & Lin, C. C., 2022, (接受/付印) 於: Journal of Geriatric Oncology.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• A pilot cross-over design study on QTc interval prolongation associated with sulpiride and haloperidol

  Su, K. P., Shen, W. W., Chuang, C. L., Chen, K. P. & Chen, C. C., 1月 1 2003, 於: Schizophrenia Research. 59, 1, p. 93-94 2 p.

  研究成果: 雜誌貢獻 › 快報 › 同行評審
  25 引文 斯高帕斯（Scopus）

• A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma

  Chang, G. C., Lan, H. C., Juang, S. H., Wu, Y. C., Lee, H. C., Hung, Y. M., Yang, H. Y., Whang-Peng, J. & Liu, K. J., 2月 15 2005, 於: Cancer. 103, 4, p. 763-771 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  42 引文 斯高帕斯（Scopus）

• Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and β4 integrin function in MDA-MB-231 breast cancer cells

  Lee, W. J., Chen, W. K., Wang, C. J., Lin, W. L. & Tseng, T. H., 1月 15 2008, 於: Toxicology and Applied Pharmacology. 226, 2, p. 178-191 14 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  151 引文 斯高帕斯（Scopus）

• A picoampere-sensitivity readout circuit for nanosensor array

  Wang, X. Z., Lei, X., Zhang, X. C., Wu, S. Y., Liu, C. J., Luo, M. C. & Li, Y. D., 1月 1 2015, 於: Nanoscience and Nanotechnology Letters. 7, 3, p. 292-295 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Apical segmental dysfunction in hypertrophic cardiomyopathy: Progression into end-stage heart failure with sudden cardiac death

  Ko, Y. L., Lin, J. L., Lei, M. I., Chen, J. J., Tsou, S. S., Kuan, P. & Lien, W. P., 1月 1 1995, 於: Cardiology (Switzerland). 86, 5, p. 436-440 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  5 引文 斯高帕斯（Scopus）

• Apical microsurgery of C-shaped maxillary first molar: A case report

  Liu, C. H., Hsieh, S. C. & Wang, H. H., 7月 2021, 於: Journal of Dental Sciences.

  研究成果: 雜誌貢獻 › 快報 › 同行評審

  開啟存取

• Apical localization of the Na-K-Cl cotransporter, rBSC1, on rat thick ascending limbs

  Kaplan, M. R., Plotkin, M. D., Lee, W. S., Xu, Z. C., Lytton, J. & Hebert, S. C., 1996, 於: Kidney International. 49, 1, p. 40-47 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取
  152 引文 斯高帕斯（Scopus）

• Apical Ballooning Syndrome: Case Report and Comprehensive Review of Pathogenesis

  貢獻的翻譯標題: 心尖球狀變化症候群: 病例報告及成因探討Lin, M. S., Chang, N-C., Huang, C-Y. & Shih, C-M., 2008, 於: 臺灣心臟超音波學會雜誌. 2, 2, p. 83-90 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis

  Lee, Y. H., Tsai, Y. S., Chang, C. C., Ho, C. C., Shih, H. M., Chen, H. M., Lai, H. L., Lee, C. W., Lee, Y. C., Liao, Y. C., Yang, U. C., Cheng, T. H., Chern, Y. & Soong, B. W., 2021, (接受/付印) 於: Movement Disorders.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  1 引文 斯高帕斯（Scopus）

• Aphonia and quadriplegia-A rare complication following epidural labor analgesia

  Liu, F. L., Cherng, Y-G. & Chang, H-C., 9月 2008, 於: Acta Anaesthesiologica Taiwanica. 46, 3, p. 142-145 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  2 引文 斯高帕斯（Scopus）

• A phase-I trial of systemic heat and adriamycin (A)

  Bull, J. M., Whang-Peng, J. & Lees, D. E., 1月 1 1979, 於: Proceedings of the American Association for Cancer Research. Vol. 20

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  5 引文 斯高帕斯（Scopus）

• A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma

  El-Khoueiry, A. B., O’Donnell, R., Semrad, T. J., Mack, P., Blanchard, S., Bahary, N., Jiang, Y., Yen, Y., Wright, J., Chen, H., Lenz, H. J. & Gandara, D. R., 5月 1 2018, 於: Cancer Chemotherapy and Pharmacology. 81, 5, p. 957-963 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  6 引文 斯高帕斯（Scopus）

• A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer

  Yen, Y., Margolin, K., Doroshow, J., Fishman, M., Johnson, B., Clairmont, C., Sullivan, D. & Sznol, M., 10月 1 2004, 於: Cancer Chemotherapy and Pharmacology. 54, 4, p. 331-342 12 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  90 引文 斯高帕斯（Scopus）

• A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer

  Chen, L. T., Liu, T. W., Wu, C. W., Chung, T. R., Shiah, H. S., Jan, C. M., Ming Liu, J., Whang-Peng, J. & Chang, J. Y., 12月 1 2002, 於: Oncology. 63, 3, p. 239-247 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  17 引文 斯高帕斯（Scopus）

• A phase i study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors

  Mortazavi, A., Ling, Y., Martin, L. K., Wei, L., Phelps, M. A., Liu, Z., Harper, E. J., Ivy, S. P., Wu, X., Zhou, B. S., Liu, X., Deam, D., Monk, J. P., Hicks, W. J., Yen, Y., Otterson, G. A., Grever, M. R. & Bekaii-Saab, T., 6月 1 2013, 於: Investigational New Drugs. 31, 3, p. 685-695 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  22 引文 斯高帕斯（Scopus）

• A phase I study of oxaliplatin in combination with gemcitabine: Correlation of clinical outcome with gene expression

  Shibata, S., Chow, W., Frankel, P., Juhasz, A., Leong, L., Lim, D., Margolin, K., Morgan, R., Newman, E., Somlo, G., Yen, Y., Synold, T., Gandara, D., Lenz, H. J. & Doroshow, J., 3月 1 2007, 於: Cancer Chemotherapy and Pharmacology. 59, 4, p. 549-557 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  4 引文 斯高帕斯（Scopus）

• A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A

  Raschko, J. W., Synold, T. W., Chow, W., Coluzzi, P., Hamasaki, V., Leong, L. A., Margolin, K. A., Morgan, R. J., Shibata, S. I., Somlo, G., Tetef, M. L., Yen, Y., Ter Veer, A. & Doroshow, J. H., 2000, 於: Cancer Chemotherapy and Pharmacology. 46, 5, p. 403-410 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  7 引文 斯高帕斯（Scopus）

• A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline

  Hong, R. L., Lin, C. H., Chao, T. Y., Kao, W. Y., Wang, C. H., Hsieh, R. K. & Hwang, W. S., 4月 2008, 於: Cancer Chemotherapy and Pharmacology. 61, 5, p. 847-853 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  8 引文 斯高帕斯（Scopus）

• A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study

  Kirschbaum, M. H., Frankel, P., Synold, T. W., Xie, Z., Yen, Y., Popplewell, L., Chen, R., Aljitawi, O., Tuscano, J. M., Chan, K. K. & Newman, E. M., 10月 2 2016, 於: Leukemia and Lymphoma. 57, 10, p. 2307-2314 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  3 引文 斯高帕斯（Scopus）

• A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older

  Chen, Y. M., Perng, R. P., Chen, M. C., Tsai, C. M., Ming-Liu, J. & Whang-Peng, J., 5月 1 2003, 於: Lung Cancer. 40, 2, p. 221-226 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  23 引文 斯高帕斯（Scopus）

• A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer

  Perng, R. P., Shih, J. F., Chen, Y. M., Delgado, F. M., Tsai, C. M., Chou, K. C., Liu, J. M., Chern, M. S. & Whang-Peng, J., 2月 1 2000, 於: American Journal of Clinical Oncology: Cancer Clinical Trials. 23, 1, p. 60-64 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  11 引文 斯高帕斯（Scopus）

• A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer

  Chen, Y. M., Perng, R. P., Yang, K. Y., Lin, W. C., Wu, H. W., Liu, J. M., Tsai, C. M. & Whang-Peng, J., 2月 1 2000, 於: American Journal of Clinical Oncology: Cancer Clinical Trials. 23, 1, p. 13-17 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  15 引文 斯高帕斯（Scopus）

• A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy

  Chen, Y. M., Perng, R. P., Tsai, C. M. & Whang-Peng, J., 6月 1 2006, 於: Lung Cancer. 52, 3, p. 333-338 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  7 引文 斯高帕斯（Scopus）

• A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma

  Chen, J. S., Chao, Y., Yang, T. S., Chou, W. C., Chen, L. T., Lee, K. D. & Lin, Y. C., 2009, 於: Cancer Chemotherapy and Pharmacology. 65, 1, p. 151-157 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  5 引文 斯高帕斯（Scopus）

• A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck

  Wang, T. F., Chu, S. C., Kao, R. H., Yao, C. Y. & Li, C. C., 8月 12 2008, 於: Japanese Journal of Clinical Oncology. 38, 7, p. 459-463 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  3 引文 斯高帕斯（Scopus）

• A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

  Li, C. P., Chen, J. S., Chen, L. T., Yen, C. J., Lee, K. D., Su, W. P., Lin, P. C., Lu, C. H., Tsai, H. J. & Chao, Y., 10月 26 2010, 於: British Journal of Cancer. 103, 9, p. 1343-1348 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  14 引文 斯高帕斯（Scopus）

• A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer

  Sridhar, S. S., Canil, C. M., Chi, K. N., Hotte, S. J., Ernst, S., Wang, L., Chen, E. X., Juhasz, A., Yen, Y., Murray, P., Zwiebel, J. A. & Moore, M. J., 4月 1 2011, 於: Cancer Chemotherapy and Pharmacology. 67, 4, p. 927-933 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  21 引文 斯高帕斯（Scopus）

• A phase II study of S-1 plus oral leucovorin in heavily treated metastatic colorectal cancer patients

  Hsu, H. C., Chou, W. C., Kuan, F. C., Lee, K. D., Rau, K. M., Huang, J. S. & Yang, T. S., 1月 1 2018, 於: Cancer Management and Research. 10, p. 6061-6070 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  3 引文 斯高帕斯（Scopus）

• A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

  Ramanathan, R. K., Belani, C. P., Singh, D. A., Tanaka, M., Lenz, H. J., Yen, Y., Kindler, H. L., Iqbal, S., Longmate, J., MacK, P. C., Lurje, G., Gandour-Edwards, R., Dancey, J. & Gandara, D. R., 9月 1 2009, 於: Cancer Chemotherapy and Pharmacology. 64, 4, p. 777-783 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  231 引文 斯高帕斯（Scopus）

• A phase II study of hydroxyurea combined with gemcitabine in patients with head and neck squamous carcinoma and gene expression profiles correlated to poor response

  Zhang, K., Kim, C., Wu, X., Loera, S., Wang, Y., Chu, P., Lim, D., Shibata, S. & Yen, Y., 2月 27 2013, 於: Head and Neck Oncology. 5, 3, 3.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

  Ciuleanu, T., Tsai, C. M., Tsao, C. J., Milanowski, J., Amoroso, D., Heo, D. S., Groen, H. J. M., Szczesna, A., Chung, C. Y., Chao, T. Y., Middleton, G., Zeaiter, A., Klingelschmitt, G., Klughammer, B. & Thatcher, N., 11月 2013, 於: Lung Cancer. 82, 2, p. 276-281 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  32 引文 斯高帕斯（Scopus）

• A phase ii study of carboplatin in nasopharyngeal carcinoma

  Chi, K. H., Chang, Y. C., Chan, W. K., Liu, J. M., Law, C. K., Lo, S. S., Shu, C. H., Yen, S. H., Whang-Peng, J. & Chen, K. Y., 1月 1 1997, 於: Oncology (Switzerland). 54, 3, p. 203-207 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  12 引文 斯高帕斯（Scopus）

• A phase II randomized trial of gefitinib alone or with Tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy

  Chen, Y. M., Fan, W. C., Tsai, C. M., Liu, S. H., Shih, J. F., Chou, T. Y., Wu, C. H., Chou, K. T., Lee, Y. C., Perng, R. P. & Whang-Peng, J., 6月 2011, 於: Journal of Thoracic Oncology. 6, 6, p. 1110-1116 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  24 引文 斯高帕斯（Scopus）

• A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly

  Chen, Y. M., Perng, R. P., Shih, J. F. & Whang-Peng, J., 8月 2008, 於: Lung Cancer. 61, 2, p. 214-219 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  19 引文 斯高帕斯（Scopus）

• A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly

  Chen, Y. M., Perng, R. P., Tsai, C. M. & Whang-Peng, J., 2月 1 2006, 於: Journal of Thoracic Oncology. 1, 2, p. 141-145 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  25 引文 斯高帕斯（Scopus）

• A phase II double-blinded study to evaluate the efficacy of EW02 in reducing chemotherapy-induced neutropenia in breast cancer

  Wu, Y. Y., Liu, H. Y., Huang, T. C., Chen, J. H., Chang, P. Y., Ho, C. L. & Chao, T. Y., 9月 1 2015, 於: Oncology Letters. 10, 3, p. 1793-1798 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  1 引文 斯高帕斯（Scopus）

• A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma

  Changou, C. A., Shiah, H. S., Chen, L. T., Liu, S., Luh, F., Liu, S. H., Cheng, Y. C. & Yen, Y., 3月 2021, 於: Oncologist. 26, 3, p. e367-e373 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取
  4 引文 斯高帕斯（Scopus）

• A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan

  Chen, J. S., Chao, Y., Hsieh, R. K., Cheng, A. L., Chen, P. M., Chiou, T. J., Chao, T. Y., Yeh, K. H., Chen, L. T. & Whang-Peng, J., 6月 2011, 於: Cancer Chemotherapy and Pharmacology. 67, 6, p. 1281-1289 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  6 引文 斯高帕斯（Scopus）

• A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions

  Perng, R. P., Wu, M. F., Lin, S. Y., Chen, Y. M., Lin, J. Y. & Whang-Peng, J., 9月 16 1997, 於: Anti-Cancer Drugs. 8, 6, p. 565-573 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  21 引文 斯高帕斯（Scopus）

• A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors

  Chiang, N. J., Chao, T. Y., Hsieh, R. K., Wang, C. H., Wang, Y. W., Yeh, C. G. & Chen, L. T., 11月 21 2016, 於: BMC Cancer. 16, 1, 907.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  24 引文 斯高帕斯（Scopus）

• A phase i clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment John T Kung

  Liu, K. J., Chao, T. Y., Chang, J. Y., Cheng, A. L., Ch'Ang, H. J., Kao, W. Y., Wu, Y. C., Yu, W. L., Chung, T. R. & Whang-Peng, J., 8月 24 2016, 於: Journal of Biomedical Science. 23, 1, 64.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  12 引文 斯高帕斯（Scopus）

• A phase I and pharmacokinetic study of oral 3-aminopyridine-2- carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: A California Cancer Consortium Study

  Chao, J., Synold, T. W., Morgan, R. J., Kunos, C., Longmate, J., Lenz, H. J., Lim, D., Shibata, S., Chung, V., Stoller, R. G., Belani, C. P., Gandara, D. R., McNamara, M., Gitlitz, B. J., Lau, D. H., Ramalingam, S. S., Davies, A., Espinoza-Delgado, I., Newman, E. M. & Yen, Y., 3月 2012, 於: Cancer Chemotherapy and Pharmacology. 69, 3, p. 835-843 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  33 引文 斯高帕斯（Scopus）